Blogs

Aug 28, 2015
Applied Clinical Trials
Will emerging drug cost assessment initiatives provide useful, valid information on total drug value?
Aug 24, 2015
Applied Clinical Trials
This month marks a landmark in the quest for personalized medicine and the growing role of big data in health sciences – from clinical development through tracking patient outcomes long after a therapy has reached the market.
Aug 21, 2015
Applied Clinical Trials
Doug Brown, director of the data sharing & partnership group in CMS’ Center for Program Integrity, acknowledges that the data on payments to PIs seem confusing.
Aug 17, 2015
Applied Clinical Trials
Cenduit has benefited greatly from the relationship we have with our parent companies, from Quintiles’ clinical development experience to Thermo Fisher Scientific’s clinical supply chain know-how.
Aug 13, 2015
Applied Clinical Trials
FDA needs to expand and empower its Office of Health & Constituent Affairs (OHCA) and its Patient Liaison Program to better coordinate interactions with individuals and physicians seeking expedited access to experimental therapies.
Aug 13, 2015
Applied Clinical Trials
CRO is the first to participate in IAOCR’s accreditation pilot.
Aug 12, 2015
Applied Clinical Trials
This article will describe my experiences in acquiring new clinical trials from the study site’s standpoint.
Aug 06, 2015
Applied Clinical Trials
Ben Rotz, Director of Medical Transparency at Eli Lilly & Company discusses TransCelerate’s Data Transparency Initiative and position paper regarding patient data de-Identification and anonymization.
Jul 17, 2015
Applied Clinical Trials
The schedule is particularly tight this time because the user fee reauthorization process coincides directly with the presidential elections.
Jul 16, 2015
Applied Clinical Trials
It appears the role of social media in post-market adverse event reporting is being taken seriously by the FDA.